S. K. Anderson

Phase Ii Trial of Vorinostat in Combination with Bortezomib in Recurrent Glioblastoma: a North Central Cancer Treatment Group Study Neuro-onco Lo Gy

E. Galanis, K. Jaeckle, E. Pajon, 2022 .

Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft models.

J. Sarkaria, K. Ballman, Wenting Wu, 2013, Neuro-oncology.

Efficacy of Protracted Temozolomide Dosing Is Limited in Mgmt Unmethylated Gbm Xenograft Models Neuro-onco Lo Gy Materials and Methods Results Initial Comparison of Tmz Dosing Regimens

J. Sarkaria, K. Ballman, J. Pokorny, 2022 .

CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design.

K. Aldape, P. Brown, M. J. van den Bent, 2020, Neuro-oncology.